| Literature DB >> 26876146 |
Matthias E Lauer1, Alexandra Graff-Meyer2, Arne C Rufer1, Cyrille Maugeais1, Elisabeth von der Mark1, Hugues Matile1, Brigitte D'Arcy1, Christine Magg3, Philippe Ringler2, Shirley A Müller2, Sebastian Scherer2, Gregor Dernick1, Ralf Thoma1, Michael Hennig4, Eric J Niesor5, Henning Stahlberg6.
Abstract
The cholesteryl ester transfer protein (CETP) enables the transfer of cholesteryl ester (CE) from high-density lipoproteins (HDL) to low-density lipoproteins (LDL) in the plasma compartment. CETP inhibition raises plasma levels of HDL cholesterol; a ternary tunnel complex with CETP bridging HDL and LDL was suggested as a mechanism. Here, we test whether the inhibition of CETP tunnel complex formation is a promising approach to suppress CE transfer from HDL to LDL, for potential treatment of cardio-vascular disease (CVD). Three monoclonal antibodies against different epitopes of CETP are assayed for their potential to interfere with CE transfer between HDL and/or LDL. Surprisingly, antibodies that target the tips of the elongated CETP molecule, interaction sites sterically required to form the suggested transfer complexes, do not interfere with CETP activity, but an antibody binding to the central region does. We show that CETP interacts with HDL, but not with LDL. Our findings demonstrate that a ternary tunnel complex is not the mechanistic prerequisite to transfer CE among lipoproteins.Entities:
Keywords: Cholesterol transport; Cholesteryl ester transfer protein; Electron microscopy; HDL; HDL remodeling; LDL
Mesh:
Substances:
Year: 2016 PMID: 26876146 DOI: 10.1016/j.jsb.2016.02.016
Source DB: PubMed Journal: J Struct Biol ISSN: 1047-8477 Impact factor: 2.867